Dr Reddys Laboratories Ltd Stock News
Dr Reddys Laboratories Ltd Share Price
Detail Overview₹1,377.90
-2.10(-0.15%)
As on 16 Nov 2026 at 15:51
As of 16 Nov 2026 at 15:51, Dr Reddys Laboratories Ltd is trading at ₹1,377.90. The 52-week range stands at ₹1,101.00–₹1,414.90, with a market cap of ₹1.15 lakh crore. At a P/E of 118.66 and a dividend yield of 0.58%, it is a large-cap stock in the Pharmaceuticals sector.
DRREDDY Price Chart
Market Cap
₹1.15L Cr
PE Ratio
118.66
ROCE
3.80%
Dr Reddys Laboratories Ltd Latest News
View More04 NOV 2026 | Wednesday
Dr. Reddy’s Laboratories granted shares to employees via stock options on November 4, 2026
30 OCT 2026 | Friday
Dr Reddys Laboratories Ltd up for third straight session
29 SEPT 2026 | Tuesday
Dr Reddys Laboratories Ltd up for third consecutive session
23 SEPT 2026 | Wednesday
Dr Reddys Laboratories Ltd spurts 0.17%, gains for fifth straight session
22 SEPT 2026 | Tuesday
Dr. Reddy’s Laboratories to review financial results at board meeting on October 23
22 SEPT 2026 | Tuesday
Dr. Reddy’s Laboratories to review financial results at a board meeting October 23, 2026
21 SEPT 2026 | Monday
Dr Reddys Laboratories Ltd spurts 1.99%
10 SEPT 2026 | Thursday
Dr. Reddy’s Laboratories allotted shares to employees under its 2007 stock option scheme
26 AUG 2026 | Wednesday
Dr. Reddy’s Laboratories allotted shares to employees under its 2002 stock option scheme
01 AUG 2026 | Saturday
Dr. Reddy’s rituximab biosimilar approved in the U.S., commercialized by Fresenius Kabi